| Literature DB >> 21199707 |
Christopher Palma1, Michael G Overstreet, Jean-Marc Guedon, Egbert Hoiczyk, Cameron Ward, Kasey A Karen, Fidel Zavala, Gary Ketner.
Abstract
Adenovirus particles can be engineered to display exogenous peptides on their surfaces by modification of viral capsid proteins, and particles that display pathogen-derived peptides can induce protective immunity. We constructed viable recombinant adenoviruses that display B-cell epitopes from the Plasmodium falciparum circumsporozoite protein (PfCSP) in the major adenovirus capsid protein, hexon. Recombinants induced high-titer antibodies against CSP when injected intraperitoneally into mice. Serum obtained from immunized mice recognized both recombinant PfCSP protein and P. falciparum sporozoites, and neutralized P. falciparum sporozoites in vitro. Replicating adenovirus vaccines have provided economical protection against adenovirus disease for over three decades. The recombinants described here may provide a path to an affordable malaria vaccine in the developing world.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21199707 PMCID: PMC3061321 DOI: 10.1016/j.vaccine.2010.12.040
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641